Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $111.62 USD
Change Today -1.81 / -1.60%
Volume 365.3K
As of 5:20 PM 08/31/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Geoffrey M. Duyk M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 106 board members in 12 different organizations across 20 different industries.

See Board Relationships


Dr. Geoffrey M. Duyk, also known as Geoff, M.D., Ph.D. serves as the Managing Director at TPG Growth. Previously, he served as a Partner and Managing Director at TPG Biotech. Dr. Duyk served as President of Research & Development at Exelixis Inc. from January 2003 to December 2003. Dr. Duyk served as Exelixis Inc.'s Executive Vice President and Chief Scientific Officer from April 1997 to December 2002. He was an Assistant Professor at Harvard Medical School and Assistant ...

Read Full Background

Corporate Headquarters*

60 Leveroni Court
Novato, California 94949

United States

Phone: 415-483-8800
Fax: 415-483-8810

Board Members Memberships*

Member of the Board of Directors
Director and Member of Nominating & Corporate Governance Committee
Director and Member of Audit Committee
Independent Director and Chairman of Nominating & Corporate Governance Committee


Case Western Reserve University
Case Western Reserve University
Post-Doctoral Training
University of California-San Francisco
BA 1980
Wesleyan University
Post-Doctoral Training
Howard Hughes Medical Institute in Dallas

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RARE:US $111.62 USD -1.81


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULTRAGENYX PHARMACEUTICAL IN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at